| The Rehabilitation Center, Inc. | |
|
155 Raymond Rd, Princeton, NJ 08540-9608 | |
| (732) 329-1181 | |
| (732) 329-1171 |
| Full Name | The Rehabilitation Center, Inc. |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 155 Raymond Rd, Princeton, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164431854 | NPI | - | NPPES |
| 1174523773 | Other | NJ | ROBERTA SCHARFF NPI |
| 1386683696 | Other | NJ | ERIN KELLY NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 40QA00445500 (New Jersey) | Primary |
| Provider Name | Roberta E Scharff |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1174523773 PECOS PAC ID: 2668433475 Enrollment ID: I20041025000961 |
News Archive
Should electrocardiograms be included in cardiovascular screening of athletes? What's the current status of research into long-term effects of concussions? These and other hot topics are the focus of the January Clinical Journal of Sport Medicine, a special issue on "Emerging Issues in Sport Medicine."
The Michigan Senate on Thursday approved legislation that would require the state Department of Community Health to develop a program to recoup costs paid by Medicaid for people who lived in nursing homes or received in-home care services before their death, the Detroit News reports.
Furiex Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office issued a patent on May 18, 2010, for the method for treatment of premature ejaculation using dapoxetine. Furiex developed dapoxetine in collaboration with Alza Corporation and its affiliates. U.S. Patent No. 7,718,705 includes claims directed to dosing dapoxetine on an as-needed basis, capturing the advantage dapoxetine has over other compounds in the same class, which require a pre-loading period for efficacy.
Amakem Therapeutics, a clinical stage ophthalmology company, today announced that first patients have commenced treatment in a Phase 2 dose-ranging study of its lead drug candidate, AMA0076 for the treatment of glaucoma.
› Verified 6 days ago
| Provider Name | Jennifer Aliguyon |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1295014082 PECOS PAC ID: 5991979049 Enrollment ID: I20120730000026 |
News Archive
Should electrocardiograms be included in cardiovascular screening of athletes? What's the current status of research into long-term effects of concussions? These and other hot topics are the focus of the January Clinical Journal of Sport Medicine, a special issue on "Emerging Issues in Sport Medicine."
The Michigan Senate on Thursday approved legislation that would require the state Department of Community Health to develop a program to recoup costs paid by Medicaid for people who lived in nursing homes or received in-home care services before their death, the Detroit News reports.
Furiex Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office issued a patent on May 18, 2010, for the method for treatment of premature ejaculation using dapoxetine. Furiex developed dapoxetine in collaboration with Alza Corporation and its affiliates. U.S. Patent No. 7,718,705 includes claims directed to dosing dapoxetine on an as-needed basis, capturing the advantage dapoxetine has over other compounds in the same class, which require a pre-loading period for efficacy.
Amakem Therapeutics, a clinical stage ophthalmology company, today announced that first patients have commenced treatment in a Phase 2 dose-ranging study of its lead drug candidate, AMA0076 for the treatment of glaucoma.
› Verified 6 days ago
| Provider Name | Milan P Patel |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1679994677 PECOS PAC ID: 5799915740 Enrollment ID: I20140313000866 |
News Archive
Should electrocardiograms be included in cardiovascular screening of athletes? What's the current status of research into long-term effects of concussions? These and other hot topics are the focus of the January Clinical Journal of Sport Medicine, a special issue on "Emerging Issues in Sport Medicine."
The Michigan Senate on Thursday approved legislation that would require the state Department of Community Health to develop a program to recoup costs paid by Medicaid for people who lived in nursing homes or received in-home care services before their death, the Detroit News reports.
Furiex Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office issued a patent on May 18, 2010, for the method for treatment of premature ejaculation using dapoxetine. Furiex developed dapoxetine in collaboration with Alza Corporation and its affiliates. U.S. Patent No. 7,718,705 includes claims directed to dosing dapoxetine on an as-needed basis, capturing the advantage dapoxetine has over other compounds in the same class, which require a pre-loading period for efficacy.
Amakem Therapeutics, a clinical stage ophthalmology company, today announced that first patients have commenced treatment in a Phase 2 dose-ranging study of its lead drug candidate, AMA0076 for the treatment of glaucoma.
› Verified 6 days ago
| Provider Name | Sara Crappse |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1881000883 PECOS PAC ID: 5698993251 Enrollment ID: I20140825000780 |
News Archive
Should electrocardiograms be included in cardiovascular screening of athletes? What's the current status of research into long-term effects of concussions? These and other hot topics are the focus of the January Clinical Journal of Sport Medicine, a special issue on "Emerging Issues in Sport Medicine."
The Michigan Senate on Thursday approved legislation that would require the state Department of Community Health to develop a program to recoup costs paid by Medicaid for people who lived in nursing homes or received in-home care services before their death, the Detroit News reports.
Furiex Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office issued a patent on May 18, 2010, for the method for treatment of premature ejaculation using dapoxetine. Furiex developed dapoxetine in collaboration with Alza Corporation and its affiliates. U.S. Patent No. 7,718,705 includes claims directed to dosing dapoxetine on an as-needed basis, capturing the advantage dapoxetine has over other compounds in the same class, which require a pre-loading period for efficacy.
Amakem Therapeutics, a clinical stage ophthalmology company, today announced that first patients have commenced treatment in a Phase 2 dose-ranging study of its lead drug candidate, AMA0076 for the treatment of glaucoma.
› Verified 6 days ago
| Provider Name | Bernard Legaspi Aurellado |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1861417503 PECOS PAC ID: 5395077804 Enrollment ID: I20191104001004 |
News Archive
Should electrocardiograms be included in cardiovascular screening of athletes? What's the current status of research into long-term effects of concussions? These and other hot topics are the focus of the January Clinical Journal of Sport Medicine, a special issue on "Emerging Issues in Sport Medicine."
The Michigan Senate on Thursday approved legislation that would require the state Department of Community Health to develop a program to recoup costs paid by Medicaid for people who lived in nursing homes or received in-home care services before their death, the Detroit News reports.
Furiex Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office issued a patent on May 18, 2010, for the method for treatment of premature ejaculation using dapoxetine. Furiex developed dapoxetine in collaboration with Alza Corporation and its affiliates. U.S. Patent No. 7,718,705 includes claims directed to dosing dapoxetine on an as-needed basis, capturing the advantage dapoxetine has over other compounds in the same class, which require a pre-loading period for efficacy.
Amakem Therapeutics, a clinical stage ophthalmology company, today announced that first patients have commenced treatment in a Phase 2 dose-ranging study of its lead drug candidate, AMA0076 for the treatment of glaucoma.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| The Rehabilitation Center, Inc. 155 Raymond Rd, Princeton, NJ 08540-9608 Ph: (732) 329-1181 | The Rehabilitation Center, Inc. 155 Raymond Rd, Princeton, NJ 08540-9608 Ph: (732) 329-1181 |
News Archive
Should electrocardiograms be included in cardiovascular screening of athletes? What's the current status of research into long-term effects of concussions? These and other hot topics are the focus of the January Clinical Journal of Sport Medicine, a special issue on "Emerging Issues in Sport Medicine."
The Michigan Senate on Thursday approved legislation that would require the state Department of Community Health to develop a program to recoup costs paid by Medicaid for people who lived in nursing homes or received in-home care services before their death, the Detroit News reports.
Furiex Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office issued a patent on May 18, 2010, for the method for treatment of premature ejaculation using dapoxetine. Furiex developed dapoxetine in collaboration with Alza Corporation and its affiliates. U.S. Patent No. 7,718,705 includes claims directed to dosing dapoxetine on an as-needed basis, capturing the advantage dapoxetine has over other compounds in the same class, which require a pre-loading period for efficacy.
Amakem Therapeutics, a clinical stage ophthalmology company, today announced that first patients have commenced treatment in a Phase 2 dose-ranging study of its lead drug candidate, AMA0076 for the treatment of glaucoma.
› Verified 6 days ago
Ms. Eileen M Kast, PT, OCS Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 26c Chicopee Dr, Princeton, NJ 08540 Phone: 609-454-0025 | |
Hina Karanjawala, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 144, Windham Court, Princeton, NJ 08540 Phone: 201-575-4409 | |
Isabelle Durocher, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 59 Woodland Dr, Princeton, NJ 08540 Phone: 819-690-1916 | |
Brian Richard Hickey, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 743 Alexander Road, Suite 2, Princeton, NJ 08540 Phone: 609-419-0455 Fax: 609-419-0023 | |
Dr. Michael Biagioli, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 325 Princeton Ave, Princeton, NJ 08540 Phone: 609-924-8131 Fax: 609-924-8532 | |
Sports Physical Therapy Institute Princeton Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 743 Alexander Road, Suite 2, Princeton, NJ 08540 Phone: 609-419-0455 Fax: 609-419-0022 | |
Frances Ertel, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 800 Bunn Dr, Suite 102, Princeton, NJ 08540 Phone: 609-683-1010 Fax: 609-683-0006 |